These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28229294)

  • 21. A comparative study of voice outcomes and complication rates in patients undergoing injection laryngoplasty performed under local versus general anaesthesia: an Adelaide voice specialist's experience.
    Chandran D; Woods C; Ullah S; Ooi E; Athanasiadis T
    J Laryngol Otol; 2017 Jan; 131(S1):S41-S46. PubMed ID: 28164775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection of cultured autologous fibroblasts for human vocal fold scars.
    Chhetri DK; Berke GS
    Laryngoscope; 2011 Apr; 121(4):785-92. PubMed ID: 21287562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB; Lee CT; Hatcher JL; Michalek J
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of outpatient unilateral medialization laryngoplasty across two academic institutions.
    Chau SM; Kim CM; Vahabzadeh-Hagh A; Verma SP; Chhetri DK
    Laryngoscope; 2019 Jul; 129(7):1647-1649. PubMed ID: 30588641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of type II thyroplasty on phonatory physiology in an excised canine larynx model.
    Devine EE; Hoffman MR; McCulloch TM; Jiang JJ
    Laryngoscope; 2017 Feb; 127(2):396-404. PubMed ID: 27223665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre- and Postoperative High-Speed Videolaryngoscopy Findings in Adductor Spasmodic Dysphonia Following Transoral CO
    Gandhi S; Bhatta S; Ganesuni D; Ghanpur AD; Saindani SJ
    J Voice; 2023 Jan; 37(1):128-133. PubMed ID: 33023813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential vibratory characteristics of adductor spasmodic dysphonia and muscle tension dysphonia on high-speed digital imaging.
    Patel RR; Liu L; Galatsanos N; Bless DM
    Ann Otol Rhinol Laryngol; 2011 Jan; 120(1):21-32. PubMed ID: 21370677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional reinnervation of vocal folds after selective laryngeal adductor denervation-reinnervation surgery for spasmodic dysphonia.
    DeConde AS; Long JL; Armin BB; Berke GS
    J Voice; 2012 Sep; 26(5):602-3. PubMed ID: 22516313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of phonosurgical methods of treatment in spasmodic dysphonia].
    Kosztyła-Hojna B; Berger G; Zdrojkowski M
    Pol Merkur Lekarski; 2017 Feb; 42(248):90-92. PubMed ID: 28258685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medialization laryngoplasty for odynophonia.
    Kupfer RA; Merati AL; Sulica L
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):556-61. PubMed ID: 25812158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
    van Esch BF; Wegner I; Stegeman I; Grolman W
    Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type I Thyroplasty Is Safe in Patients Undergoing Antithrombotic Therapy.
    Sawatsubashi M; Umezaki T; Kikuchi Y; Adachi K; Nakagawa T
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):163-171. PubMed ID: 37100042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overall evaluation of effectiveness of type II thyroplasty for adductor spasmodic dysphonia.
    Sanuki T; Isshiki N
    Laryngoscope; 2007 Dec; 117(12):2255-9. PubMed ID: 17921901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications after type one thyroplasty: is day-case surgery feasible?
    Bray D; Young JP; Harries ML
    J Laryngol Otol; 2008 Jul; 122(7):715-8. PubMed ID: 18384701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of type II thyroplasty for adductor spasmodic dysphonia.
    Chan SW; Baxter M; Oates J; Yorston A
    Laryngoscope; 2004 Sep; 114(9):1604-8. PubMed ID: 15475790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical Interventions for Pediatric Unilateral Vocal Cord Paralysis: A Systematic Review.
    Butskiy O; Mistry B; Chadha NK
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):654-60. PubMed ID: 25973887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of acute injection laryngoplasty for vocal cord paralysis following thoracic surgery.
    Graboyes EM; Bradley JP; Meyers BF; Nussenbaum B
    Laryngoscope; 2011 Nov; 121(11):2406-10. PubMed ID: 21994176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airway and Respiration Parameters Improve Following Vocal Fold Medialization: A Prospective Study.
    Asik MB; Karasimav O; Birkent H; Merati AL; Gerek M; Yildiz Y
    Ann Otol Rhinol Laryngol; 2015 Dec; 124(12):972-7. PubMed ID: 26121983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.